218 related articles for article (PubMed ID: 3384883)
1. Simultaneous determination of imipramine, desipramine and their deuterium-labelled analogues in biological fluids by capillary gas chromatography-mass spectrometry.
Sasaki Y; Baba S
J Chromatogr; 1988 Apr; 426(1):93-101. PubMed ID: 3384883
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous measurement of imipramine and desipramine by selected ion recording with deuterated internal standards.
Claeys M; Muscettola G; Markey SP
Biomed Mass Spectrom; 1976 Jun; 3(3):110-6. PubMed ID: 990418
[TBL] [Abstract][Full Text] [Related]
3. Thin-layer chromatographic determination of imipramine and desipramine in human plasma and urine at single-dose levels.
Sistovaris N; Dagrosa EE; Keller A
J Chromatogr; 1983 Oct; 277():273-81. PubMed ID: 6643612
[TBL] [Abstract][Full Text] [Related]
4. Gas chromatographic-mass fragmentographic determation of "steady-state" plasma levels of imipramine and desipramine in chronically treated patients.
Belvedere G; Burti L; Frigerio A; Pantarotto C
J Chromatogr; 1975 Sep; 111(2):313-21. PubMed ID: 1159010
[TBL] [Abstract][Full Text] [Related]
5. A sensitive colorimetric method for the determination of imipramine hydrochloride and desipramine hydrochloride.
el-Yazbi FA; Korany MA; Bedair M
J Clin Hosp Pharm; 1985 Dec; 10(4):373-7. PubMed ID: 4093508
[TBL] [Abstract][Full Text] [Related]
6. Stable isotope coadministration methodology for the estimation of the fraction of imipramine metabolized to desipramine.
Sasaki Y; Shinohara Y; Baba S
J Pharm Sci; 1990 Feb; 79(2):96-8. PubMed ID: 2324970
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous analysis of imipramine and its metabolite desipramine in biological fluids.
Craig JC; Gruenke LD; Nguyen TL
J Chromatogr; 1982 Apr; 239():81-6. PubMed ID: 7096509
[TBL] [Abstract][Full Text] [Related]
8. Sensitive microanalysis of imipramine and desipramine in single rat thyroids by gas chromatography-mass spectrometry.
Rousseau A; Marquet P; Comby F; Buxeraud J; Raby C; Lachâtre G
J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):93-100. PubMed ID: 9200522
[TBL] [Abstract][Full Text] [Related]
9. A sensitive method for the simultaneous determination in biological fluids of imipramine and desipramine or clomipramine and N-desmethylclomipramine by gas chromatography mass spectrometry.
Alkalay D; Volk J; Carlsen S
Biomed Mass Spectrom; 1979 May; 6(5):200-4. PubMed ID: 476283
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of imipramine and its metabolite desipramine in human plasma by capillary gas chromatography with mass-selective detection.
Pommier F; Sioufi A; Godbillon J
J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):147-58. PubMed ID: 9448071
[TBL] [Abstract][Full Text] [Related]
11. Quantitative mapping of metabolites of imipramine and desipramine in plasma samples by gas chromatographic-mass spectrometry.
Narasimhachari N; Saady J; Friedel RO
Biol Psychiatry; 1981 Oct; 16(10):937-44. PubMed ID: 7306616
[TBL] [Abstract][Full Text] [Related]
12. Gas-chromatographic analysis for therapeutic concentration of imipramine and disipramine in plasma, with use of a nitrogen detector.
Bailey DN; Jatlow PI
Clin Chem; 1976 Oct; 22(10):1697-701. PubMed ID: 975516
[TBL] [Abstract][Full Text] [Related]
13. A sensitive GLC method for the determination of imipramine and desmethylimipramine using a nitrogen detector.
Cooper TB; Allen D; Simpson GM
Psychopharmacol Commun; 1975; 1(4):445-54. PubMed ID: 1224013
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a new GLC-AFID method with a GLC-MS selected ion monitoring technique and a radioimmunoassay for the determination of plasma concentrations of imipramine and desipramine.
Midha KK; Charette C; Cooper JK; McGilveray IJ
J Anal Toxicol; 1980; 4(5):237-43. PubMed ID: 7442136
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous high-performance liquid chromatography-electrochemical detection determination of imipramine, desipramine, their 2-hydroxylated metabolites, and imipramine N-oxide in human plasma and urine: preliminary application to oxidation pharmacogenetics.
Koyama E; Kikuchi Y; Echizen H; Chiba K; Ishizaki T
Ther Drug Monit; 1993 Jun; 15(3):224-35. PubMed ID: 8333003
[TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatography of imipramine and six metabolites in human plasma and urine.
Nielsen KK; Brøsen K
J Chromatogr; 1993 Jan; 612(1):87-94. PubMed ID: 8454708
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of imipramine, desipramine and their 2- and 10-hydroxylated metabolites in human plasma and urine by high-performance liquid chromatography.
Chen AG; Wing YK; Chiu H; Lee S; Chen CN; Chan K
J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):153-8. PubMed ID: 9200529
[TBL] [Abstract][Full Text] [Related]
18. Impurities in drugs I: Imipramine, desipramine, and their formulations.
McErlane KM; Curran NM; Lovering EG
J Pharm Sci; 1977 Jul; 66(7):1015-8. PubMed ID: 886436
[TBL] [Abstract][Full Text] [Related]
19. GLC method for iminodibenzyl and desipramine impurities in imipramine hydrochloride and its formulated products.
Thompson DW
J Pharm Sci; 1982 May; 71(5):536-8. PubMed ID: 7097500
[TBL] [Abstract][Full Text] [Related]
20. Isotope dilution gas chromatographic-mass spectrometric measurement of tricyclic antidepressant drugs. Utility of the 4-carbethoxyhexafluorobutyryl derivatives of secondary amines.
Way BA; Stickle D; Mitchell ME; Koenig JW; Turk J
J Anal Toxicol; 1998 Sep; 22(5):374-82. PubMed ID: 9737332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
